PMN - ProMIS Neurosciences, Inc. Stock Price, Fair Value and News

$0.92+0.02 (+2.22%)

Delayed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

PMN Price Action

Last 7 days

-1.1%

Last 30 days

-8%

Last 90 days

-25.2%

Trailing 12 Months

-20%

PMN RSI Chart

PMN Valuation

Market Cap

30.1M

Price/Earnings (Trailing)

-53.38

Price/Free Cashflow

-1.35

PMN Price/Earnings (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

PMN Fundamentals

PMN Earnings

Earnings (TTM)

-563.3K

Earnings Growth (Yr)

492.94%

Earnings Growth (Qtr)

453.55%

PMN Profitability

Return on Equity

-7.75%

Return on Assets

-2.3%

Free Cashflow Yield

-73.9%

PMN Investor Care

Shares Dilution (1Y)

73.09%

Diluted EPS (TTM)

-0.07

Revenue & Growth

About ProMIS Neurosciences, Inc.

ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines neurodegenerative diseases and other misfolded protein diseases in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267, a TDP-43; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.

CEO	Dr. Gail M. Farfel Ph.D.
WEBSITE	promisneurosciences.com
SECTOR	Healthcare
INDUSTRY	Biotechnology
EMPLOYEES	6

ProMIS Neurosciences, Inc. Frequently Asked Questions

What is the ticker symbol for ProMIS Neurosciences, Inc.? What does PMN stand for in stocks?

PMN is the stock ticker symbol of ProMIS Neurosciences, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of ProMIS Neurosciences, Inc. (PMN)?

As of Fri Dec 20 2024, market cap of ProMIS Neurosciences, Inc. is 30.07 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of PMN stock?

You can check PMN's fair value in chart for subscribers.

Is ProMIS Neurosciences, Inc. a good stock to buy?

The fair value guage provides a quick view whether PMN is over valued or under valued. Whether ProMIS Neurosciences, Inc. is cheap or expensive depends on the assumptions which impact ProMIS Neurosciences, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for PMN.

What is 5 year return on ProMIS Neurosciences, Inc.'s stock?

In the past 10 years, ProMIS Neurosciences, Inc. has provided -0.229 (multiply by 100 for percentage) rate of return.